Biopharma’s New Realities in the Era of “New Health Economy”

Loading Map....

Date — Sep 22
3:30 pm - 7:00 pm

The Nippon Club


Tuesday, September 22, 2015
3:30 – 5:30 PM – Program

 5:30 – 7:00 PM – Reception

(click here for speaker bios)
  • Roger Longman, CEO,  Real Endpoints 
  • Ben Comer, Senior Manager, PwC Health Research Institute

Biopharma’s New Realities in the Era of “New Health Economy”

Significant changes in the overall healthcare environment, with new technologies and greater access to consumer/patient data, are driving new types of collaboration among biopharma companies, other healthcare stakeholders and new types of players. In addition, with prices of specialty drugs continuing to rise, drug pricing is making more of an impact on drug choices that payers, providers and even patients are making. The “New Health Economy,” as it is called by consulting firm PricewaterhouseCoopers (PwC), presents both challenges and opportunities for biopharma companies.

At this program, three experts will discuss the major shift in the whole healthcare landscape and what it means for biopharma companies, and the transformation they need to prepare themselves for.

PwC recently conducted interviews with various stakeholders to understand the new landscape for collaboration and identify opportunities. The report notes, “New collaborations are reconfiguring three crucial business operations: drug R&D, regulatory submission and product commercialization. The need to collaborate also stems from a growing concern that drug development doesn’t adequately address patient needs and medication adherence outside of the clinic.” Douglas Strang and Ben Comer of PwC will share critical findings from their research that would impact the biopharma companies.

Roger Longman, founder and CEO of Real Endpoints, which specializes in pharmaceutical reimbursement, states, “In a therapeutics world where value is defined both medically and economically, the first player to market – or the player with what will only be temporarily viewed as the best product – won’t necessarily be the ultimate winner.” He will explain what it takes to be a winner and why.

3:30 – 5:30 PM Program
5:30 – 7:00 PM Reception

The Nippon Club – Rose Room, 2nd Floor
145 West 57th Street, 2nd Floor
New York City

Regular Members 
– Up to 4 guests admitted free; $90 per additional attendee
Associate Members – $130 per person
Non-Members – $130 per person

Reservations or cancellations for this event will not be accepted after 12 noon on Monday, Sept. 21, 2015.  Please note that cancellations must be made in writing by email or fax before this date.  Those who reserve but don’t attend will be charged.